1. |
Wallace DJ. The clinical presentation of systemic lupus erythematosus. In: Wallace DJ, Hahn BH, editors. Dubois' lupus erythematosus. 5th ed. Baltimore (Maryland): Williams & Wilkins; 1997 .p.627-33.
|
2. |
Rossi D, Zlotnik A. The biology of chemokines and their receptors. Ann Rev Immunol 2000; 18:217-42.
|
3. |
Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000; 12:121-7.
|
4. |
Lanzavecchia A, Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 2000; 290:92-7.
|
5. |
Sallusto F, Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Ann Rev Immunol 2000; 18:593-620.
|
6. |
Luther SA, Cyster JG. Chemokines as regulators of T cell differentiation. Nat Immunol 2001; 2:102-7.
|
7. |
Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol 2001; 2:108-15.
|
8. |
Mackay CR. Chemokines: immunology's high impact factors. Nat Immunol 2001; 2:95-101.
|
9. |
Stasikowska O, Danilewicz M, Wagrowska-Danilewicz M. The significant role of RANTES and CCR5 in progressive tubulointerstitial lesions in lupus nephropathy. Pol J Pathol 2007; 58:35-40.
|
10 |
Wenzel J, Proelss J, Wiechert A, et al. CXCR3-mediated recruitment of cytotoxic lymphocytes in lupus erythematosus profundus. J Am Acad Dermatol 2007; 56:648- 50.
|
11 |
Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271-7.
|
12 |
Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 1992; 35:630-40.
|
13 |
Nagase H, Miyamasu M, Yamaguchi M, et al. Expression of CXCR4 in eosinophils: functional analyses and cytokine- mediated regulation. J Immunol 2000; 164:5935-43.
|
14 |
Huber TB, Reinhardt HC, Exner M, et al. Expression of functional CCR and CXCR chemokine receptors in podocytes. J Immunol 2002; 168:6244-52.
|
15 |
Bauer JW, Baechler EC, Petri M, et al. Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus. PLoS Med 2006; 3:2274-84.
|
16 |
Odegard JM, DiPlacido LD, Greenwald L, et al. ICOS controls effector function but not trafficking receptor expression of kidney-infiltrating effector T cells in murine lupus. J Immunol 2009; 182:4076-84.
|
17 |
Enghard P, Humrich JY, Rudolph B, et al. CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients. Arthritis Rheum 2009; 60:199-206.
|
18 |
Al-Saleh J, el-Eissawy S. The role of T helper cell subsets in pathogenesis of Systemic Lupus Erythematosus and their relation to disease activity. Egypt J Immunol 2006; 13:41-8.
|
19 |
Segerer S, Nelson PJ, Schlndorff D. Chemokines, che- mokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 2000; 11:152-76.
|
20 |
Kikuchi T, Andarini S, Xin H, et al. Involvement of fractalkine/CX3CL1 expression by dendritic cells in the enhancement of host immunity against legionella pneumophila. Infect Immun 2005; 73:5350-7.
|
21 |
Fraticelli P, Sironi M, Bianchi G, et al. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest 2001; 107:1173-81.
|
22 |
Huang H, Li F, Cairns CM, et al. Neutrophils and B cells express XCR1 receptor and chemotactically respond to lymphotactin. Biochem Biophys Res Commun 2001; 281: 378-82.
|
23 |
Yao X, Chen ZQ, Li YM, et al. Correlation between some Th1 and Th2 cytokine receptor gene polymorphisms and systemic lupus erythematosus in Chinese patients. Int J Dermatol 2007; 46:1129-35.
|
24 |
Mamtani M, Rovin B, Brey R, et al. CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus. Ann Rheum Dis 2008; 67:1076-83.
|